1.Pyeloduodenal Fistula Successfully Treated By Endoscopic Ligation without Surgical Nephrectomy: Case Report.
Kyung Nam LEE ; In Hye HWANG ; Min Ji SHIN ; Soo Bong LEE ; Il Young KIM ; Dong Won LEE ; Harin RHEE ; Byeong Yun YANG ; Eun Young SEONG ; Ihm Soo KWAK
Journal of Korean Medical Science 2014;29(1):141-144
A 74-yr-old woman presented with fever and abdominal discomfort. She was in a septic condition caused by urinary tract infection. Her computed tomogram of the abdomen revealed features of hydronephrosis with ureteral stones in both kidneys. During percutaneous nephrostomies, right pyeloduodenal fistula (PDF) was diagnosed. Elective surgery was originally planned but the patient was in a poor condition to undergo surgery. Instead, 2 times endoscopic clipping and ligation by endoloop were applied with parenteral antibiotics for the fistula lesion. On admission day 30, she was discharged from the hospital after confirmation of no more contrast leakage on fistulography. We reviewed the literature and discuss the etiologies, clinical presentations, diagnosis, and treatment of PDF.
Aged
;
Duodenal Diseases/complications/radiography/*surgery
;
Female
;
Humans
;
Hydronephrosis/complications/radiography
;
Intestinal Fistula/complications/radiography/*surgery
;
Kidney/radiography/surgery
;
Kidney Calculi/complications/radiography
;
Kidney Diseases/complications/radiography/*surgery
;
Ligation
;
Urethral Obstruction/complications/radiography
;
Urinary Fistula/complications/radiography/*surgery
;
Urinary Tract Infections/complications/radiography
2.Bowel Perforation after Erlotinib Treatment in a Patient with Non-Small Cell Lung Cancer.
Yun Hong CHEON ; Moon Jin KIM ; Min Gyu KANG ; Hee Jin KIM ; Sang Su LEE ; Cha Young KIM ; Dae Hong JEON ; Yu Eun KIM ; Gyeong Won LEE
Yonsei Medical Journal 2011;52(4):695-698
Erlotinib is accepted as a standard second-line chemotherapeutic agent in patients with non-small cell lung cancer who are refractory or resistant to first-line platinum-based chemotherapy. There has been no previous report of bowel perforation with or without gastrointestinal metastases related to erlotinib in patients with non-small cell lung cancer. The exact mechanism of bowel perforation in patients who received erlotinib remains unclear. In this report, we report the first case of enterocutaneous fistula in a female patient with metastatic non-small cell lung cancer 9 months, following medication with erlotinib as second-line chemotherapy.
Aged
;
Antineoplastic Agents/*adverse effects/therapeutic use
;
Carcinoma, Non-Small-Cell Lung/complications/*drug therapy
;
Female
;
Humans
;
Intestinal Fistula/*chemically induced/complications/radiography/surgery
;
Intestinal Perforation/*chemically induced/complications/radiography/surgery
;
Protein Kinase Inhibitors/*adverse effects/therapeutic use
;
Quinazolines/*adverse effects/therapeutic use
;
Sigmoid Diseases/*chemically induced/complications/radiography/surgery